Brief Report: Treatment of Tumor Necrosis Factor-Transgenic Mice With Anti-Tumor Necrosis Factor Restores Lymphatic Contractions, Repairs Lymphatic Vessels, and May Increase Monocyte/Macrophage Egress

Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40047
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Tumor Necrosis Factor

2004English

Golimumab: A Novel Anti-Tumor Necrosis Factor

Biologics in Therapy
2013English

Infliximab (Anti–Tumor Necrosis Factor Α Antibody)

Archives of Dermatology
2001English

Macrophage/Monocyte Receptor for Nonenzymatically Glycosylated Protein Is Upregulated by Cachectin/Tumor Necrosis Factor.

Journal of Clinical Investigation
Medicine
1989English

Selective Improvement of Tumor Necrosis Factor Capture in a Cytokine Hemoadsorption Device Using Immobilized Anti-Tumor Necrosis Factor

Journal of Biomedical Materials Research - Part B Applied Biomaterials
Biomedical EngineeringBiomaterials
2010English

Left Ventricular Remodeling in Transgenic Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Vasculoprotective Effects of Anti-Tumor Necrosis Factor-Α Treatment in Aging

American Journal of Pathology
Forensic MedicinePathology
2007English

Insulin-Like Growth Factor-I Ameliorates Demyelination Induced by Tumor Necrosis Factor-Α in Transgenic Mice

Journal of Neuroscience Research
Molecular NeuroscienceCellular
2007English

Tumor Necrosis Factor-Alpha Inhibitor Treatment for Sarcoidosis

Therapeutics and Clinical Risk Management
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy